Citric Acid Gene Set

Dataset DrugBank Drug Targets
Category physical interactions
Type drug
Description A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms. (Chemical Entities of Biological Interest Ontology, CHEBI_30769)
External Link http://www.drugbank.ca/drugs/DB04272
Similar Terms
Downloads & Tools

Genes

24 interacting proteins for the Citric Acid drug from the curated DrugBank Drug Targets dataset.

Symbol Name
AKR1B1 aldo-keto reductase family 1, member B1 (aldose reductase)
ANG angiogenin, ribonuclease, RNase A family, 5
APRT adenine phosphoribosyltransferase
BHMT betaine--homocysteine S-methyltransferase
C8G complement component 8, gamma polypeptide
CPB1 carboxypeptidase B1 (tissue)
CS citrate synthase
CTDSP1 CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1
GNMT glycine N-methyltransferase
HGS hepatocyte growth factor-regulated tyrosine kinase substrate
HS3ST3A1 heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1
IL4I1 interleukin 4 induced 1
ITPA inosine triphosphatase (nucleoside triphosphate pyrophosphatase)
LSM6 LSM6 homolog, U6 small nuclear RNA associated (S. cerevisiae)
MDH2 malate dehydrogenase 2, NAD (mitochondrial)
MIF macrophage migration inhibitory factor (glycosylation-inhibiting factor)
PDE5A phosphodiesterase 5A, cGMP-specific
PLEKHA1 pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1
RNASE1 ribonuclease, RNase A family, 1 (pancreatic)
RNASE3 ribonuclease, RNase A family, 3
SLCO2B1 solute carrier organic anion transporter family, member 2B1
SRC SRC proto-oncogene, non-receptor tyrosine kinase
TNFSF13B tumor necrosis factor (ligand) superfamily, member 13b
UCK2 uridine-cytidine kinase 2